ALL COMPANIES

This company uses AAV-based viral vectors to deliver a gene. These vectors will be injected into the subthalamic nucleus in...

This company is developing lentiviral vectors (viruses) to deliver three genes that are involved in the production of dopamine.  So...

Prevail is developing AAV vectors carrying the gene that contains the instructions to produce the glucocerebrosidase enzyme.  Some people with...

This company is developing AAVs (viral vectors) which encode for antibodies and also contain miRNA to suppress the production of...

AAV2-GDNF is a gene therapy that delivers GDNF (glial cell line-derived neurotrophic factor) agonists to enhance neuron survival and regeneration,...

This company is developing compounds to reduce the production of harmful proteins that gut bacteria secrete, and which can contribute...

Rifaximin is a small molecule antibiotic. It targets gut bacteria to reduce inflammation and potentially improve motor impairment. This approach...

Fecal Transfer is a biologic therapy designed to modulate the fecal microbiota (microbiome modulator). By transferring healthy gut microbiota from...

CNM-Au8 uses bioenergetics through gold nanocrystals to improve cellular energy production. By enhancing mitochondrial function and cellular metabolism, CNM-Au8 aims...